METASTATIC COLORECTAL CANCER (CRC)
Clinical trials for METASTATIC COLORECTAL CANCER (CRC) explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL CANCER (CRC) trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL CANCER (CRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail targets advanced colon cancer in 68-Patient trial
Disease control Not yet recruitingThis study tests a combination of four drugs (irinotecan liposome, capecitabine, bevacizumab, and camrelizumab) in 68 adults with metastatic colorectal cancer that has worsened after first-line therapy. The goal is to see if this mix can slow cancer growth or shrink tumors. Parti…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated May 26, 2026 10:54 UTC
-
New hope for advanced gut cancers? drug combo trial launches
Disease control Not yet recruitingThis study tests a new drug called SSGJ-706 combined with standard treatments for people with advanced cancers of the stomach, colon, pancreas, or esophagus that cannot be removed by surgery. About 300 adults aged 18-75 will take part to see if the combination is safe and helps s…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated May 26, 2026 10:46 UTC
-
New hope for advanced colon cancer: drug cocktail trial launches
Disease control Not yet recruitingThis study tests a combination of four drugs (iparomlimab, tuvonralimab, bevacizumab, and chemotherapy) as a first treatment for people with advanced colorectal cancer that cannot be surgically removed. The goal is to see if this mix can shrink tumors and delay cancer growth. Abo…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated May 26, 2026 10:46 UTC
-
New combo aims to extend life in Tough-to-Treat colorectal cancer
Disease control Not yet recruitingThis study tests whether a new drug combination (fruquintinib plus trifluridine/tipiracil) works better than a standard combination (bevacizumab plus trifluridine/tipiracil) for people with advanced colorectal cancer that has not responded to prior treatments. About 292 adults ag…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 10:46 UTC
-
New hope for advanced colorectal cancer: DNA-Guided drug rechallenge tested
Disease control Not yet recruitingThis study tests whether giving a second round of a targeted drug combination (irinotecan plus cetuximab) works better than the current standard treatment for people with advanced colorectal cancer that has spread. Only patients whose tumor DNA shows certain genetic markers are e…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: Gruppo Oncologico Italia Meridionale • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New hope for hard-to-treat colon cancer? early trial launches
Disease control Not yet recruitingThis early-phase study tests whether adding the experimental drug SAR445877 to standard chemotherapy (FOLFOX6) and a targeted therapy (bevacizumab) is safe for people with advanced colorectal cancer that is microsatellite stable (MSS). About 41 adults who have not yet received tr…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New drug combo aims to improve second-line treatment for advanced colorectal cancer
Disease control Not yet recruitingThis study tests whether a liposomal (encapsulated) form of irinotecan combined with other drugs works better than standard irinotecan for people with metastatic colorectal cancer that has progressed after first-line treatment. About 408 adults aged 18-75 will be randomly assigne…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2, PHASE3 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated May 18, 2026 12:12 UTC
-
New hope for advanced colon cancer: drug cocktail plus radiation tested
Disease control Not yet recruitingThis study is for people with metastatic colorectal cancer that has spread to a few spots (like the liver or lungs) and hasn't responded to at least two prior treatments. It tests whether adding two immunotherapy drugs (iparomlimab and tuvonralimab) plus targeted radiation to the…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated May 18, 2026 11:59 UTC